Boston, MA -- (SBWIRE) -- 08/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Dole Food Company, Inc.(NYSE:DOLE), Coeur d'Alene Mines Corporation (NYSE:CDE), Novavax, Inc. (NASDAQ:NVAX)
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares gained 5.17% to $3.46. The company on August 22 announced that the British Journal of Cancer has published the paper "A Multinational Phase 2 Study of Nanoliposomal Irinotecan Sucrosofate (PEP02, MM-398) for Patients with Gemcitabine-Refractory Metastatic Pancreatic Cancer" in its latest issue (Volume 109, Issue 4). The Phase 2 study evaluated MM-398 (liposomal irinotecan sucrosulfate) monotherapy in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy.
How Should Investors Trade MACK After The Recent Volatility? Get Free Report Here
Dole Food Company, Inc.(NYSE:DOLE) shares increased 0.44% and closed at $13.77. DOLE and David H. Murdock, Dole's Chairman and Chief Executive Officer, on August 12 jointly announced that they have signed a definitive merger agreement pursuant to which Mr. Murdock, acting through his affiliates, will acquire for cash all of the outstanding shares of Dole common stock not currently beneficially held by him. Under the terms of the merger agreement, Dole stockholders will receive $13.50 in cash for each share of Dole common stock that they hold, in a transaction which (with the assumption of debt) places the total enterprise value of Dole at approximately $1.6 billion.
How Should Investors Trade DOLE After The Recent Volatility? Get Free Report Here
Coeur d'Alene Mines Corporation (NYSE:CDE) shares increased 2.59% to $15.85. The company on August 8 reported metal sales of $204.5 million, cash flow from operating activities of $63.3 million, or $0.63 per share, and capital expenditures of $27.2 million during the second quarter 2013. The Company produced 4.6 million ounces of silver and 60,757 ounces of gold during the second quarter 2013, representing increases of 21% and 7%, respectively, over the first quarter 2013. Silver and gold production at the Palmarejo mine in Mexico increased 24% and 23%, respectively, compared to the first quarter.
Is CDE A Good Buy After The Recent Price Movement? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) shares gained 0.35% to $2.90. The company on August 22 announced the number of shares tendered to it during the extended acceptance period for its recommended public offer to acquire all issued and outstanding shares and warrants (warrants series 2005-I and 2005-II) of Isconova AB ("Isconova"), which was first communicated on June 4, 2013, (the "Offer"), and which was extended to August 20, 2013.
Is NVAX A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)